| Trial ID: | L2759 |
| Source ID: | NCT00232362
|
| Associated Drug: |
Pioglitazone (Actos)
|
| Title: |
Effect of Pioglitazone on Left Ventricular Diastolic Function in Type 2 Diabetes Mellitus
|
| Acronym: |
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Pioglitazone (Actos)|DRUG: Anti-diabetic agent other than pioglitazone or rosiglitazone
|
| Outcome Measures: |
Primary: Improvement in diastolic function parameters: early peak to late peak velocity (E/A) ratio|deceleration time (DT)|isovolumic relaxation time (IVRT)|E/A ratio percent change with Valsalva maneuver more than 40%|annular tissue Doppler velocity |
|
| Sponsor/Collaborators: |
Sponsor: Texas Tech University Health Sciences Center
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE1
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose:
|
| Start Date: |
2007-06
|
| Completion Date: |
2008-06
|
| Results First Posted: |
|
| Last Update Posted: |
2015-04-13
|
| Locations: |
|
| URL: |
https://clinicaltrials.gov/show/NCT00232362
|
